Systemic therapy in the management of metastatic or advanced salivary gland cancers

Area of Science:

• Oncology
• Cancer Research
• Medical Science

Background:

• Salivary gland cancers are rare, heterogeneous tumors with poor outcomes.
• Limited prospective data exist, hindering standard treatment recommendations.
• Systemic therapy options for these cancers are not well-established.

Purpose of the Study:

• To comprehensively review existing studies on systemic therapies for salivary gland cancers.
• To evaluate the role of chemotherapy, targeted therapy, and hormone therapy.
• To provide an overview of current treatment strategies for these rare tumors.

Main Methods:

• Exhaustive literature search of studies investigating systemic therapies.
• Inclusion of case reports and small studies on chemotherapy agents.
• Review of research on targeted therapies based on molecular pathways.

Main Results:

• Chemotherapy has been investigated in various case reports and small studies.
• Targeted therapies are emerging due to discoveries in cancer signaling pathways.
• Hormone therapy has also been explored as a systemic treatment option.

Conclusions:

• Systemic therapy for salivary gland cancers remains an area with limited evidence.
• Further research is needed to establish standardized treatment protocols.
• Chemotherapy, targeted therapy, and hormone therapy represent current avenues for investigation.